Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-05-22

Clinical Trial Update: Cranial-nerve Non-invasive Neuromodulation (CN-NINM) for Balance Deficits After Mild Traumatic Brain Injury (Full Trial) [NA]

View source ↗

Summary

A clinical trial evaluating cranial-nerve non-invasive neuromodulation for balance deficits after mild traumatic brain injury has been withdrawn; no phase infor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Mild Traumatic Brain Injury | NA | Status: WITHDRAWN